Common Indoor Mold and Pulmonary Disease Associated With Them

CHEST 2022 Coverage

S. Cherian

ATS 2022: Approach to Lung Nodules in 2022

Shaheen Islam

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

Approaching Sarcoidosis Therapy From a 21st Century Perspective

CHEST 2022 Coverage

D. Culver

A Radiologist's Approach to Subsolid Pulmonary Nodules

CHEST 2022 Coverage

A. Guttentag

Classification, Diagnosis and Management of Pulmonary Hypertension: …

Icahn School of Medicine at Mount Sinai

R. Benza

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

UCLA Health

J. Belperio

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

An Update on Parapneumonic Effusions

McMaster University Department of Medicine

M. Chari

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

Sarcoidosis: Diagnosis and Management

University of Colorado Department of Medicine

N. Held

Hydrocortisone Reduces Mortality by 48% in Severe Community-Acquired…

MedCram

R. Seheult

Short Course Antibiotic Therapy

McMaster University Department of Medicine

B. Spellberg

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush

Infectious Disease Update - What’s New in ID?

McMaster University Department of Medicine

A. Kapoor

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher

Management of Pulmonary Fibrosis in Clinical Practice

National Jewish Health

J. Solomon

Defining the Molecular Natural History of Early and Progressive Pulm…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

N. Banovich

Challenges in ILD: Prediction With or Without Big Data

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Fingerlin

Critical Care Literature Review

Medical College of Georgia - Augusta University

W. T Browne